| |
|
|
|
TRACON Pharmaceuticals- Inc.
|
|
3.00 -0.05 (-1.64%) |
10/23/2017 4:00pm |
|
Open: |
3.15 |
Pre close: |
3.05 |
Target:
|
4.10
|
|
High: |
3.15 |
Low: |
2.95 |
Resistance:
|
3.51
3.95
|
|
Volume: |
287,763 |
Market Cap: |
49.97M |
Support:
|
2.80
2.33
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.99
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
3.30 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
2.66  |
Stochastic Oscillator |
%K(14,3):
|
18.05 |
|
MA(250): |
3.77 |
%D(3): |
15.19 |
|
Average Volume(K) |
3-Month: |
15540
|
52-Week |
High:
|
7.30 |
|
10-Days: |
9707 |
Low: |
2.00 |
|
RSI |
RSI(14):
|
41.53 |
Change(%): |
-49.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.750 |
Return on Equity (ttm) |
-146.4 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-44.0 |
Shares Float (M) |
9.24 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.81 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
-21.8 |
% Held by Institutions |
48.14 |
|
Forward EPS |
-1.831 |
Gross Profit (p.s.) |
0.207 |
Shares Short (K) |
325 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
-1.491 |
P/E |
-1.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.30 |
P/S |
277666656.00 |
|
Operating Margin |
-926.81 |
Levered Free Cash Flow
(M) |
-14.12 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
